期刊文献+

人胰腺癌组织中Cyclin D_1基因表达 被引量:1

Expression of Cyclin D 1 Gene in Tissues of Human Adenocarcinoma of Pancreas
下载PDF
导出
摘要 胰腺癌是常见的、预后最差的恶性肿瘤之一,其发生、发展与癌基因密切相关。目的 研究癌基因在胰腺癌发生发展中的作用,为胰腺癌的诊断、评估预后和指导治疗提供依据。方法 对21例胰腺癌手术切除标本和10例非肿瘤性胰腺组织进行免疫组化检测,所有检测均采用Envision二步法。结果 (1)21例胰腺癌中CyclinD1的表达率为76.2%(16/21)。与非肿瘤胰腺组织中的表达率相比,有显著差异(P<0.05)。(2)CyclinD1的表达与胰腺癌的病理分级、分期无关。结论 CyclinD1在胰腺癌发生、发展中发挥着作用。 Purpose Adenocarcinoma of pancreas (ACP) is one of the common malignant tumors with worst prognosis. Its genesis and development are closely relevant with oncogene. Study the effects of oncogene on genesis and development of ACP and try to find out the evidences providing for proof of diagnosis, evaluating prognosis and guiding the treatment of ACP. Methods 21 resected tumor tissue samples and 10 non-tumor pancreatic tissues were examined by immunohistochemical detector with Envision two steps method. Results 1. The positive expression of Cyclin D 1 in samples of ACP was 73.2 % (16/21). In comparing with the expression rate of non-tumor pancreatic tissues (0/10), the difference was obvious ( P < 0.05 ). 2. The expression of Cyclin D 1 had no correlation with the pathologic grading and staging of ACP. Conclusion Cyclin D 1 gene does have effects on genesis and development of ACP, detection of Cyclin D 1 protein products can benefit for diagnosis of ACP.
出处 《苏州医学院学报》 2000年第2期114-115,共2页 Acta Academiae Medicinae Suzhou
关键词 胰腺肿瘤 基因表达 CYCLIND1基因 Adenocarcinoma of pancreas Oncogene Immunohistochemistry
  • 相关文献

参考文献1

  • 1Jiang W,Cancer Res,1992年,52卷,2980页

同被引文献11

  • 1Jawhari A, Jordan S, Poole S, et al. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma relationship with patient survival [J]. Gastroenterology, 1997, 112 (1): 46.
  • 2Peifer M. β-catenin as oncogene: The smoking gun[J]. Science, 1997, 275: 1752-1753.
  • 3Brabletz T, Jung A, Kirchner T. β-catenin and the morphogenesis of colorectal cancer[J]. Virchow Arch, 2001, 441: 1-11.
  • 4Wang N, Pignatelli M. β-catenin A linchpin in colorectal carcinogenesis[J]. Am J Pathol, 2002, 160(2): 389-401.
  • 5Caca K, Kolligs FT, Ji X, et al. Beta and gamma-catenin mutations, but not E-cadherin inactivation,underlie T-cell factor /lymphoid enhancer factor transcriptional deregalation in gastric and pancreatic cancer[J]. Cell Growth Differ, 1999, 10(6):369-376.
  • 6Joo YE, Rew JS,Park CS. Expression of E-cadherin,alph- and beta-catenin in patients with pancreatic adenocarcinoma[J]. Pancreatology, 2002, 2(2): 1329-1337.
  • 7Gerdes B,Ramas WA,Simon B, et al. Analysis of beta-catenin gene mutation in pancreatic tumors[J]. Digestion, 1999, 60(6): 544-548 .
  • 8Sincha Z. The CyclinD1 gene is a target of the β-catenin/LEF-1 pathway[J]. Proc Natl Acad Sci USA, 1999, 96:5522-5527.
  • 9Suannna G, Frank G, Marco R, et al. Overexpression of cyclinD1 in human pancreatic carcinomas is essociated with poor prognosis[J]. Cancer Res, 1997,57(5):1634-1637.
  • 10Qiao Q, Ramadani M,Gansauge S,et al. Reduced membranous and ectopic cytoplasmic expression of beta catenin correlate with cyclinD1 overexpression and poor prognosis in pancreatic cancer[J]. Int J Cancer, 2001,95(3):194-197.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部